Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

In May, the U.S. Food and Drug Administration (FDA) approved the first at-home cervical cancer screening tool, developed by ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

-Only MCED test to use a urine sample collected at home instead of blood draw. -Only MCED to detect stage I/II cancers with 97% sensitivity and 97% specificity. -Offered as a laboratory-developed test ...

Self-administered HPV tests involve inserting a plastic tube — similar to a tampon — into the vagina, then twisting the ...

A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...

Signatera can detect tumor DNA in the bloodstream. A new blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating ...

Experts say cervical cancer screening should be every woman's 2026 health resolution as better tests, easier access and ...